210 related articles for article (PubMed ID: 26784191)
1. Alternative Splicing in Adhesion- and Motility-Related Genes in Breast Cancer.
Aversa R; Sorrentino A; Esposito R; Ambrosio MR; Amato A; Zambelli A; Ciccodicola A; D'Apice L; Costa V
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26784191
[TBL] [Abstract][Full Text] [Related]
2. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte common antigen-related tyrosine phosphatase receptor: increased expression and neuronal-type splicing in breast cancer cells and tissue.
Yang T; Zhang JS; Massa SM; Han X; Longo FM
Mol Carcinog; 1999 Jun; 25(2):139-49. PubMed ID: 10365916
[TBL] [Abstract][Full Text] [Related]
4. Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site.
Tessier SJ; Loiselle JJ; McBain A; Pullen C; Koenderink BW; Roy JG; Sutherland LC
BMC Res Notes; 2015 Feb; 8():46. PubMed ID: 25889998
[TBL] [Abstract][Full Text] [Related]
5. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
6. Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene.
Watermann DO; Tang Y; Zur Hausen A; Jäger M; Stamm S; Stickeler E
Cancer Res; 2006 May; 66(9):4774-80. PubMed ID: 16651431
[TBL] [Abstract][Full Text] [Related]
7. CDK12 regulates alternative last exon mRNA splicing and promotes breast cancer cell invasion.
Tien JF; Mazloomian A; Cheng SG; Hughes CS; Chow CCT; Canapi LT; Oloumi A; Trigo-Gonzalez G; Bashashati A; Xu J; Chang VC; Shah SP; Aparicio S; Morin GB
Nucleic Acids Res; 2017 Jun; 45(11):6698-6716. PubMed ID: 28334900
[TBL] [Abstract][Full Text] [Related]
8. Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model.
Hurst DR; Xie Y; Edmonds MD; Welch DR
Clin Exp Metastasis; 2009; 26(2):89-96. PubMed ID: 18841483
[TBL] [Abstract][Full Text] [Related]
9. Expression of Semaphorin 3C in Breast Cancer and its Impact on Adhesion and Invasion of Breast Cancer Cells.
Malik MF; Satherley LK; Davies EL; Ye L; Jiang WG
Anticancer Res; 2016 Mar; 36(3):1281-6. PubMed ID: 26977026
[TBL] [Abstract][Full Text] [Related]
10. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.
Driouch K; Prydz H; Monese R; Johansen H; Lidereau R; Frengen E
Oncogene; 2002 Mar; 21(12):1832-40. PubMed ID: 11896615
[TBL] [Abstract][Full Text] [Related]
11. A candidate chimeric mammalian mRNA transcript is derived from distinct chromosomes and is associated with nonconsensus splice junction motifs.
Zhang C; Xie Y; Martignetti JA; Yeo TT; Massa SM; Longo FM
DNA Cell Biol; 2003 May; 22(5):303-15. PubMed ID: 12941158
[TBL] [Abstract][Full Text] [Related]
12. Human gene MOB: structure specification and aspects of transcriptional activity.
Vladychenskaya IP; Dergunova LV; Dmitrieva VG; Limborska SA
Gene; 2004 Sep; 338(2):257-65. PubMed ID: 15315829
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia is a Key Driver of Alternative Splicing in Human Breast Cancer Cells.
Han J; Li J; Ho JC; Chia GS; Kato H; Jha S; Yang H; Poellinger L; Lee KL
Sci Rep; 2017 Jun; 7(1):4108. PubMed ID: 28642487
[TBL] [Abstract][Full Text] [Related]
14. Tissue specificity and regulation of the N-terminal diversity of reticulon 3.
Di Scala F; Dupuis L; Gaiddon C; De Tapia M; Jokic N; Gonzalez de Aguilar JL; Raul JS; Ludes B; Loeffler JP
Biochem J; 2005 Jan; 385(Pt 1):125-34. PubMed ID: 15350194
[TBL] [Abstract][Full Text] [Related]
15. Analysis of SEMA6B gene expression in breast cancer: identification of a new isoform.
D'Apice L; Costa V; Valente C; Trovato M; Pagani A; Manera S; Regolo L; Zambelli A; Ciccodicola A; De Berardinis P
Biochim Biophys Acta; 2013 Oct; 1830(10):4543-53. PubMed ID: 23665584
[TBL] [Abstract][Full Text] [Related]
16. Alternative splicing variant of RHBDD2 is associated with cell stress response and breast cancer progression.
Canzoneri R; Rabassa ME; Gurruchaga A; Ferretti V; Palma S; Isla-Larrain M; Croce MV; Lacunza E; Abba MC
Oncol Rep; 2018 Aug; 40(2):909-915. PubMed ID: 29901166
[TBL] [Abstract][Full Text] [Related]
17. The MUC3 gene encodes a transmembrane mucin and is alternatively spliced.
Williams SJ; Munster DJ; Quin RJ; Gotley DC; McGuckin MA
Biochem Biophys Res Commun; 1999 Jul; 261(1):83-9. PubMed ID: 10405327
[TBL] [Abstract][Full Text] [Related]
18. An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer.
Li J; Choi PS; Chaffer CL; Labella K; Hwang JH; Giacomelli AO; Kim JW; Ilic N; Doench JG; Ly SH; Dai C; Hagel K; Hong AL; Gjoerup O; Goel S; Ge JY; Root DE; Zhao JJ; Brooks AN; Weinberg RA; Hahn WC
Elife; 2018 Jul; 7():. PubMed ID: 30059005
[TBL] [Abstract][Full Text] [Related]
19. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
Loh TJ; Moon H; Cho S; Jang H; Liu YC; Tai H; Jung DW; Williams DR; Kim HR; Shin MG; Liao DJ; Zhou J; Shi W; Zheng X; Shen H
Oncol Rep; 2015 Sep; 34(3):1231-8. PubMed ID: 26151392
[TBL] [Abstract][Full Text] [Related]
20. Alternative splicing factor or splicing factor-2 plays a key role in intron retention of the endoglin gene during endothelial senescence.
Blanco FJ; Bernabeu C
Aging Cell; 2011 Oct; 10(5):896-907. PubMed ID: 21668763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
